Altered distribution of RhoA in Alzheimer's disease and AβPP overexpressing mice

Journal of Alzheimer's Disease

Volumn 19, Issue 1, 2010, Pages 37-56

  Huesa, Gema ^a   Baltrons, María Antonia ^b   Gómez Ramos, Pilar ^c   Morán, Asunción ^c   García, Agustina ^b   Hidalgo, Juan ^a,b   Francés, Silvia ^a   Santpere, Gabriel ^d   Ferrer, Isidre ^d   Galea, Elena ^a,e  

^a INSTITUT DE NEUROCIÈNCIES   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

^e INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

Actin; Cytoskeleton; Microtubules; Neurofibrillary tangles; Pick's disease; Synaptic terminals; Tau

Indexed keywords

AMYLOID BETA PROTEIN; P21 ACTIVATED KINASE; PROTEIN CDC42; RAC1 PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; COMPARATIVE STUDY; CONTROLLED STUDY; DENDRITE; ELECTRON MICROSCOPY; ENZYME ACTIVITY; GENE MUTATION; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROTUBULE; MOUSE; NERVE CELL; NEUROFIBRILLARY TANGLE; NEUROPIL; NONHUMAN; PICK PRESENILE DEMENTIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SYNAPSE;

EID: 75149156695     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-1203     Document Type: Article

References (29)

1. Kaech S, Parmar H, Roelandse M, Bornmann C, Matus A (2001) Cytoskeletal microdifferentiation: a mechanism for organizing morphological plasticity in dendrites. Proc Natl Acad Sci USA 19, 7086-7092. (Pubitemid 32567907)
2. Scheff SW, Price DA (2003) Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies. Neurobiol Aging 24, 1029-1046.
3. Heredia L, Helguera P, de Olmos S, Kedikian G, Soĺa Vigo F, LaFerla F, Staufenbiel M, de Olmos J, Busciglio J, Ćaceres A, Lorenzo A (2006) Phosphorylation of actin-depolymerizing factor/cofilin by LIM-kinase mediates amyloid beta-induced degeneration: a potential mechanism of neuronal dystrophy in Alzheimer's disease. J Neurosci 26, 6533-6542.
4. Ma QL, Yang F, Calon F, Ubeda OJ, Hansen JE,Weisbar RH, BeechW, Frautschy SA, ColeGM(2008) P21-activated kinase aberrant activation and translocation in Alzheimer's disease pathogenesis. J Biol Chem 283, 14132-14143.
5. Petratos S, Li QX, George AJ, Hou X, Kerr ML, Unabia SE, Hatzinisiriou I, Maksel D, Aguilar MI, Small DH (2008) The beta-amyloid protein of Alzheimer's disease increases neuronal CRMP-2 phosphorylation by a RhoA-GTP mechanism. Brain 131, 90-108.
6. Hernandez F, Avila J (2008) Tau aggregates and tau pathology. J Alzheimers Dis 14, 449-452.
7. Jaffe AB, Hall A (2005) RhoA GTPases: biochemistry and biology. Annu Rev Cell Dev Biol 21, 247-269.
8. Amano M, Kaneko T, Maeda A, Nakayama M, Ito M, Yamauchi T, Goto H, Fukata Y, Oshiro N, Shinohara A, Iwamatsu A, Kaibuchi K (2003) Identification of Tau and MAP2 as novel substrates of RhoA-kinase and myosin phosphatase. J Neurochem 87, 780-790.
9. Linseman DA, Loucks FA (2008) Diverse roles of RhoA family GTPases in neuronal development, survival and death. Front Biosci 13, 657-676.
10. Khelfaoui M, Denis C, Van Galen E, de Bock F, Schmitt A, Houbron C, Morice E, Giros B, Ramakers G, Fagni L, Chelly J, Nosten-Bertrand M, Billuart P (2007) Loss of X-linked mental retardation gene Oligophrenin1 in mice impairs spatial memory and leads to ventricular enlargement and dendritic spine immaturity. J Neurosci 27, 9439-9450.
11. Zhao L, Ma QL, Calon F (2006) Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease. Nat Neurosci 9, 234-242.
12. Dickson DW(1998) Pick's disease: a modern approach. Brain Pathol 8, 339-354.
13. Braak H, Braak E, Peter J (1999) Temporal sequence of Alzheimer's disease related pathology. In Cerebral cortex, vol 14, Neurodegenerative and age-related changes in structure and function of cerebral cortex, Peters A, Morrison JH (eds). Kluwer Academic/Plenum Publishers, New York, pp. 475- 512.
14. Bergeron C, Morris HR, Rossor M (2003) Pick's disease. In Neurodegeneration: The molecular pathology of dementia and dementia with movement disorders, Dickson D. (ed). ISN Neuropath Press, Basel, pp. 124-131.
15. Bragina L, Candiracci C, Barbaresi P, Giovedi S, Benfenati F, Conti F (2007) Heterogeneity of glutamatergic and GABAergic release machinery in cerebral cortex. Neuroscience 146, 1829-1840.
16. Henny P, Jones BE (2008) Projections from basal forebrain to prefrontal cortex comprise cholinergic, GABAergic and glutamatergic inputs to pyramidal cells or interneurons. Eur J Neurosci 27, 654-670.
17. Tashiro A, Yuste R (2008) Role of Rho GTPases in the morphogenesis and motility of dendritic spines. Methods Enzymol 439, 285-302.
18. Hiley E, McMullan R, Nurrish SJ (2006) The Galpha12-RGS RhoAGEF-RhoA signalling pathway regulates neurotransmitter release in C. elegans. EMBO J 25, 5884-5895.
19. Sayas CL, Moreno-Flores MT, Avila J, Wandosell F (1999) The neurite retraction induced by lysophosphatidic acid increases Alzheimer's disease-like Tau phosphorylation. J Biol Chem 274, 37046-37052.
20. Dergham P, Ellezam B, Essagian C, Avedissian H, Lubell WD, McKerracher L (2002) RhoA signaling pathway targeted to promote spinal cord repair. J Neurosci 22, 6570-6577.
21. Lacor PN, Buniel MC, Chang L, Fernandez SJ, Gong Y, Viola KL, Lambert MP,Velasco PT, Bigio EH, Finch CE, Krafft GA, Klein WL (2004) Synaptic targeting by Alzheimer's-related amyloid beta oligomers. J Neurosci 4, 10191-10200.
22. Sarmiere PD, Bamburg JR (2004) Regulation of the neuronal actin cytoskeleton by ADF/cofilin. J Neurobiol 58, 103-117.
23. Waiczies S, Bendix I, Zipp F (2008) Geranylgeranylation but not GTP-loading of RhoAGTPases determines Tcell function. Sci Signal 1, pt3.
24. Cordle A,Koenigsknecht-Talboo J,WilkinsonB(2005) Mechanisms of statin-mediated inhibition of small G-protein function. J Biol Chem 280, 34202-34209.
25. Cole AR, Noble W, van AL, Plattner F, Meimaridou R, Hogan D, Taylor M, LaFrancois J., Gunn-Moore F, Verkhratsky A, Oddo S, LaFerla F, Giese KP, Dineley KT, Duff K, Richardson JC, Yan SD, Hanger DP, Allan SM, Sutherland C (2007) Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer's disease progression. J Neurochem 103, 1132-1144.
26. Ma QL, Teter B, Ubeda OJ, Morihara T, Dhoot D, Nyby MD, Tuck ML, Frautschy SA, Cole GM (2007) Omega-3 fatty acid docosahexaenoic acid increases SorLA/LR11, a sorting protein with reduced expression in sporadic Alzheimer's disease (AD): relevance to AD prevention. J Neurosci 27, 14299-14307.
27. Calon F, Lim GP, Morihara T, Yang F, Ubeda O, Salem N Jr, Frautschy SA, Cole GM (2005) Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer's disease. Eur J Neurosci 22, 617-626
28. Fritz G, Kaina B (2006) Rho GTPases: promising cellular targets for a novel anticancer drugs. Curr Cancer Drug Targets 1, 1-14.
29. Olson MF (2008) Applications for ROCK kinase inhibition. Curr Opin Cell Biol 20, 242-248.